Your session is about to expire
← Back to Search
Composite Resin
SHOFU Beautifil II LS for Noncarious Cervical Lesions
N/A
Waitlist Available
Led By Gerard Kugel, DMD, MS, PhD
Research Sponsored by Tufts University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 18 months
Awards & highlights
Study Summary
This trial will compare the clinical effectiveness of a new composite resin (SHOFU Beautifil II LS) vs a control (3M/ESPE Filtek Supreme) for restoring non carious cervical lesions (class V lesions).
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hickel Criteria
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SHOFU Beautifil II LSExperimental Treatment1 Intervention
Composite: SHOFU Beautifil II LS, Bonding Agent: SHOFU BeautiBond
Group II: 3M/ESPE Filtek SupremeActive Control1 Intervention
Composite: 3M/ESPE Filtek Supreme, Bonding Agent: 3M/ESPE Scotchbond Universal
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SHOFU Beautifil II LS
2017
N/A
~50
Find a Location
Who is running the clinical trial?
Tufts UniversityLead Sponsor
261 Previous Clinical Trials
661,273 Total Patients Enrolled
Shofu Inc.Industry Sponsor
2 Previous Clinical Trials
74 Total Patients Enrolled
Gerard Kugel, DMD, MS, PhDPrincipal InvestigatorTufts University School of Dental Medicine
2 Previous Clinical Trials
308 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger